Primary regulatory
STEP 1: Semaglutide for Obesity: ClinicalTrials.gov
ClinicalTrials.gov registry for STEP 1, the pivotal semaglutide obesity trial.
ClinicalTrials.govPublished 2018-06-01Accessed 2026-07-01
Registry record
Source metadata
- Publisher
- ClinicalTrials.gov
- Source type
- Primary regulatory
- Registry ID
clinicaltrials-gov-step1
Interpretation boundary
What this record can and cannot establish
Inclusion in the registry is not endorsement. The record supports only the claims that fit its design, population, date, and scope. Company, media, and community records can document that a claim was made without proving the claim itself.